If it’s absolutely legal and ethical and in the state’s best interest for the Crime Lab to contract with a company owned by its assistant director, and if no bidding is necessary on the specific item being purchased, why pay extra for a middleman? read more >
Some University of Arkansas for Medical Sciences employees saw red flags long before auditors discovered a deficit at the Myeloma Institute for Research & Therapy that was allowed to grow to $29 million over nine years. read more >
Dr. Gareth Morgan, former director of the Myeloma Institute for Research & Therapy at the University of Arkansas for Medical Sciences in Little Rock, said $29 million in operating losses detected by a recent audit were “accounting errors” outside his control. read more >
When the University of Arkansas for Medical Sciences announced in April 2014 that Dr. Gareth Morgan would lead the Myeloma Institute for Research & Therapy, it was cause for a celebration. The cheers didn’t last long. read more >
The audit of the Myeloma Institute should be able to determine if there’s any money unaccounted for in the cancer program. The accounting is expected to be final after January. read more >
Tiffani Foltz has been named a director of development for the University of Arkansas for Medical Sciences in Little Rock, where she will focus on fundraising activities for the Myeloma Institute. read more >
Dr. Bart Barlogie said that at the myeloma program at Mount Sinai he’ll be doing clinical care and research and “dedicating myself to finding answers to high-risk myeloma,” just as he did at UAMS. read more >
Celgene Corp. of Summit, New Jersey, announced Monday that it is giving $10 million to the Myeloma Institute at the University of Arkansas for Medical Sciences. read more >
The University of Arkansas for Medical Sciences has named Dr. Bart Barlogie as a distinguished professor of medicine and pathology in the College of Medicine in a resolution from the University of Arkansas System Board of Trustees. read more >
